This House resolution supports testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening. It also calls on medical associations and guideline-setting groups to recommend routine APS testing. The resolution says APS can raise the risk of blood clots, pregnancy loss, and other pregnancy complications, and that it can be detected with a blood test.
The resolution expresses support for routine prenatal APS testing and asks medical groups to update their recommendations. It does not itself require doctors or clinics to provide the test.
No publicly available information.
The resolution states that routine testing could help identify APS during pregnancy and reduce pregnancy loss and grief for families.
No publicly available information.